Novo Nordisk Dives 6% After Unexpectedly Releasing Earnings A Day Early

Novo Nordisk (NVO) stock plummeted Tuesday after the obesity kingpin unexpectedly released its second-quarter earnings a day early. The company put up roughly $12.1 billion in sales, easily beating forecasts for $10.89 billion, according to FactSet. That's partially thanks to the new Wegovy pill, which has reached more than 5 million prescriptions in the U.S. since its launch. "Management believes…